Until Wegovys MASH indication, patients with F2F3 fibrosis lacked any FDAapproved pharmacologic therapy targeting steatohepatitis resolution and fibrosis improvement, relying primarily on lifestyle modification and bariatric surgery. Against this background, semaglutides ability to deliver sustained doubledigit percentage weight loss, improve cardiometabolic markers, reduce MACE, and favorably modify histologic endpoints in MASH positions Wegovy as a versatile agent across cardiometabolic care pathways, provided its risks and limitations are fully understood and respected
The trunk was naturally straight, the head was upright, and both eyes were looking straight ahead (the lowest point of the upper edge of the tragus and the lower edge of the eye socket was at the same level)
The benzyl alcohol stops bacterial growth, which is what lets a reconstituted vial be used across multiple doses over several weeks in the fridge
For many individuals, meaningful benefit may require long-term or lifelong use, similar to other maintenance medications used in chronic conditions